A leading Indian pharmaceutical company, Cipla stock price fell nearly 7% on November 23, 2023, following the revelation of a warning letter issued by the United States Food and Drug Administration (USFDA) regarding its Madhya Pradesh facility. Key Details of the Warning Letter The USFDA’s warning letter highlighted data integrity issues at Cipla’s Pithampur facility, …